|
Status |
Public on Jan 31, 2007 |
Title |
A30180 |
Sample type |
RNA |
|
|
Source name |
bone marrow from AML patient
|
Organism |
Homo sapiens |
Characteristics |
AML class: REFRACTORY Sex: MALE Age: 62 Best Response: No response Survival time: 72
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was isolated from bone marrow of AML patients using Qiagen Rneasy Kit.
|
Label |
biotin
|
Label protocol |
Approximately 5 µg of total RNA was processed to produce biotinylated cRNA targets.
|
|
|
Hybridization protocol |
standard Affymetrix procedures
|
Scan protocol |
standard Affymetrix procedures
|
Description |
NA
|
Data processing |
Affymetrix Microarray Suite version 5.0
|
|
|
Submission date |
Jun 21, 2006 |
Last update date |
Dec 03, 2008 |
Contact name |
Jack Yu |
E-mail(s) |
jyu9@VRXUS.jnj.com
|
Phone |
858-320-3362
|
Fax |
858-784-3182
|
Organization name |
Veridex, LLC
|
Street address |
3210 Merryfield Row
|
City |
San Diego |
State/province |
CA |
ZIP/Postal code |
92121 |
Country |
USA |
|
|
Platform ID |
GPL96 |
Series (1) |
GSE5122 |
Identification of molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory AML |
|